Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at PacBio (NASDAQ:PACB) and its peers.
The DNA foundation model Evo 2 has been published in the journal Nature. Trained on the DNA of over 100,000 species across ...
Their makers claim they can detect dozens of cancer types — but some scientists say they could be missing many cancers or ...
Late in 2025, we covered the development of an AI system called Evo that was trained on massive numbers of bacterial genomes. So many that, when prompted with sequences from a cluster of related genes ...
Finding out how microbes make compounds containing the diazo chemical group could help researchers to synthesize useful ...
Smithsonian researcher Sarah Johnson studies bison specimens to understand how the species’s genetic diversity changed after its decline ...
Scientists are trying to understand how complex life emerged on Earth about 2 billion years ago. Our microbial ancestors could be the key.
Researchers at the Peter Doherty Institute for Infection and Immunity (Doherty Institute) have developed a world-first ...
As CROs and CDMOs expand their role in biopharma development and manufacturing, fast, accurate bioanalytic technologies remain critical to biotherapeutic affordability ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results